Structure of and influence of a tick complement inhibitor on human complement component 5
about
Emerging drugs for Guillain-Barré syndromeStructural basis for activation of the complement system by component C4 cleavageSubstrate recognition by complement convertases revealed in the C5-cobra venom factor complexPutting the structure into complementThe Crystal Structure of Cobra Venom Factor, a Cofactor for C3- and C5-Convertase CVFBbSolution Structure of Factor I-like Modules from Complement C7 Reveals a Pair of Follistatin Domains in Compact Pseudosymmetric ArrangementStructural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitorStructural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureusAssembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9.Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArgInhibiting Alternative Pathway Complement Activation by Targeting the Factor D ExositeBifunctional Lipocalin Ameliorates Murine Immune Complex-induced Acute Lung InjuryCrystal Structure of C5b-6 Suggests Structural Basis for Priming Assembly of the Membrane Attack ComplexStructural and functional characterization of human and murine C5a anaphylatoxinsStructure of a bacterial α2-macroglobulin reveals mimicry of eukaryotic innate immunityStructural basis for therapeutic inhibition of complement C5Structural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal PathwaySerine Protease Inhibitors in Ticks: An Overview of Their Role in Tick Biology and Tick-Borne Pathogen Transmission.Structure and mechanism in salivary proteins from blood-feeding arthropods.Functional basis for complement evasion by staphylococcal superantigen-like 7.Novel complement inhibitor limits severity of experimentally myasthenia gravisA tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent.Manipulation of the complement system for benefit in sepsis.Molecular insights into the surface-specific arrangement of complement C5 convertase enzymes.Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humansComplement activation, regulation, and molecular basis for complement-related diseasesC5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assay.Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.Guillain-Barré syndrome: update on immunobiology and treatment.Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer.Structural insight into proteolytic activation and regulation of the complement system.The structure and function of thioester-containing proteins in arthropods.The mystery behind membrane insertion: a review of the complement membrane attack complexDevelopment of Autologous C5 Vaccine Nanoparticles to Reduce Intravascular Hemolysis in Vivo.Novel Mutations Causing C5 Deficiency in Three North-African Families.Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases.Stratification of responders towards eculizumab using a structural epitope mapping strategy.Mimer: an automated spreadsheet-based crystallization screening system.Distinct localization of the complement C5b-9 complex on Gram-positive bacteria.Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.
P2860
Q22241376-274C270D-C37A-4BDD-A1B7-8957E42692EBQ24298033-82590C70-6D48-4E1A-82CE-844C032DA6D9Q24336071-9945FB5C-6AE7-466C-88AE-0DC7CB74342BQ26828812-A32E33D3-54E3-49E0-821A-C6468F4FFAB6Q27654785-5DCC9D60-8668-4F84-9F8B-9D11A6F95453Q27655389-D9456DA7-14CF-4EA6-ABD9-0497263D79D5Q27655786-DEE7AE56-7CA8-4AF4-BA83-02500B4948BBQ27659556-1D970327-6C2D-4152-9E0D-E942220240BBQ27670907-539A2A58-9610-4DAF-A558-570DD2452DBCQ27675246-EB464AE8-0B93-4689-A095-9C6E2CF3B8E4Q27677455-F56B766A-3E9C-4795-8372-E8DD9267BCE0Q27677832-CC18B837-66C5-4E0F-AC40-FB1087A46E72Q27678501-2A792BA6-A928-4295-883F-0986785D7D9EQ27684270-A3261408-823D-426D-B3B6-BC42B399F591Q27695619-5B852874-F7D1-49C8-977D-ABB29F758A71Q27704314-64794B09-5875-4000-A030-1792FEE888BDQ27704898-E698A002-BA02-4D36-A7D2-D49D1A3C11EBQ33710724-552DBE81-2BA8-48E5-89F1-98C33DEE1536Q33926835-371D5F2D-5BA7-416F-AD3B-0F611EE29F8AQ34137944-0B3F7386-E28C-4C29-B4BF-09877E98204AQ34604158-939B52E3-BDFD-4D7B-9075-4863C374F8A3Q35207953-2E1AFECC-3BF0-49CB-A22F-1475A3621B12Q35829670-6BEAA44D-4AAB-4875-97DE-7A4532F2092CQ35836382-D6972615-0894-4163-BC73-6D3B45414BFFQ35987250-A3920782-DA10-4951-9CCF-ACED18191350Q36380682-9D89D03C-85B6-4AF8-8BD9-7C95DF7129BAQ36463676-9A0BD95F-041E-41AE-8BCA-E2364336F655Q36906411-B69E9329-0B10-4F4E-B32F-C3A5436F878FQ37600859-8A9A47EB-A218-4CC2-8216-F7E00B731EAAQ38299564-2D68B32E-9A26-4234-A5F1-F36298B2CDD7Q38991069-9B4848DB-928F-44D3-98FE-0F111285E4ABQ39217886-1CA12D94-6D4B-4CE5-8D30-716AEDF91BBFQ39384364-F6477CCF-CD73-446B-8C34-9AEA0DF3F63EQ40398444-C86B7227-CB20-485D-8FD6-98E41247C6B0Q40736568-F00F73E9-215D-445F-B584-549FF631DFE1Q41953134-E831381A-9FC0-43D9-BC87-94D7CD24EAE6Q42364725-9B28B815-6F44-4B84-8896-501F07C8F12DQ43105197-92557D32-1B87-4E2E-8254-A76AF69C8CBDQ47976585-00045C29-F4ED-44BF-89F3-A2EA08D90D10Q48502611-FC09381E-8094-47AD-B3EF-376C73C2C279
P2860
Structure of and influence of a tick complement inhibitor on human complement component 5
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Structure of and influence of a tick complement inhibitor on human complement component 5
@ast
Structure of and influence of a tick complement inhibitor on human complement component 5
@en
Structure of and influence of a tick complement inhibitor on human complement component 5
@nl
type
label
Structure of and influence of a tick complement inhibitor on human complement component 5
@ast
Structure of and influence of a tick complement inhibitor on human complement component 5
@en
Structure of and influence of a tick complement inhibitor on human complement component 5
@nl
prefLabel
Structure of and influence of a tick complement inhibitor on human complement component 5
@ast
Structure of and influence of a tick complement inhibitor on human complement component 5
@en
Structure of and influence of a tick complement inhibitor on human complement component 5
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Structure of and influence of a tick complement inhibitor on human complement component 5
@en
P2093
Jan S Pedersen
Lars Sottrup-Jensen
Miles A Nunn
Nick S Laursen
Richard Discipio
P2507
P2860
P304
P3181
P356
10.1038/NI.1625
P407
P577
2008-06-08T00:00:00Z